Hancock Whitney Corp Dynavax Technologies Corp Transaction History

Hancock Whitney Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	SELL	$11.7 - $14.98 $5,159 - $6,606	-441 Reduced 1.91%	22,647 $281,000
Q4 2023 Feb 14, 2024	SELL	$13.09 - $14.98 $615 - $704	-47 Reduced 0.2%	23,088 $322,000
Q3 2023 Nov 13, 2023	SELL	$12.64 - $14.99 $9,227 - $10,942	-730 Reduced 3.06%	23,135 $341,000
Q2 2023 Nov 13, 2023	SELL	$9.85 - $13.17 $131,261 - $175,503	-13,326 Reduced 35.83%	23,865 $308,000
Q2 2023 Aug 10, 2023	SELL	$9.85 - $13.17 $131,261 - $175,503	-13,326 Reduced 35.83%	23,865 $308,000
Q1 2023 Nov 13, 2023	SELL	$9.44 - $11.88 $12,460 - $15,681	-1,320 Reduced 3.43%	37,191 $364,000
Q1 2023 May 16, 2023	SELL	$9.44 - $11.88 $12,460 - $15,681	-1,320 Reduced 3.43%	37,191 $365,000
Q4 2022 Nov 13, 2023	BUY	$10.27 - $13.29 $150,414 - $194,645	14,646 Added 61.37%	38,511 $409,000
Q4 2022 Feb 03, 2023	BUY	$10.27 - $13.29 $67,761 - $87,687	6,598 Added 20.67%	38,511 $410,000
Q3 2022 Oct 26, 2022	SELL	$9.93 - $17.44 $132,833 - $233,294	-13,377 Reduced 29.54%	31,913 $333,000
Q2 2022 Aug 08, 2022	SELL	$7.45 - $12.83 $12,925 - $22,260	-1,735 Reduced 3.69%	45,290 $570,000
Q1 2022 May 12, 2022	BUY	$9.75 - $14.44 $458,493 - $679,041	47,025 New	47,025 $510,000
Q4 2020 Feb 09, 2021	SELL	$3.73 - $5.6 $53,182 - $79,844	-14,258 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$4.32 - $11.7 $23,155 - $62,711	-5,360 Reduced 27.32%	14,258 $62,000
Q2 2020 Jul 30, 2020	BUY	$2.94 - $9.1 $57,676 - $178,523	19,618 New	19,618 $174,000

259

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.41B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.